Inhibitory effects of clinical reagents having anti-oxidative activity on transforming growth factor-β1-induced expression of α-smooth muscle actin in human fetal lung fibroblasts

Journal of Toxicological Sciences

Volumn 36, Issue 6, 2011, Pages 733-740

  Matsuzawa, Yasuo ^a   Kawashima, Tatsuo ^a   Yamazaki, Risa ^b   Yamaura, Erika ^b   Makiyama, Tomohiko ^b   Fujino, Hiromichi ^b   Murayama, Toshihiko ^b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Fibrosis; HFL1 cells; Lovastatin; Probucol; TGF 1

Indexed keywords

ACETYLCYSTEINE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TOCOPHEROL; MEVINOLIN; PROBUCOL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; FETUS LUNG; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PROTEIN EXPRESSION;

EID: 82855180226     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.733     Document Type: Article

References (35)

1. Alexeeff, S.E., Litonjua, A.A., Sparrow, D., Vokonas, P.S. and Schwartz, J. (2007): Statin use reduces decline in lung function: VA Normative Aging Study. Am. J. Respir. Crit. Care Med., 176, 742-747.
2. Blaauboer, M.E., Smit, T.H., Hanemaaijer, R., Stoop, R. and Everts, V. (2011): Cyclic mechanical stretch reduces myofibroblast differentiation of primary lung fibroblasts. Biochem. Biophys. Res. Commun., 404, 23-27.
3. DiCamillo, S.J., Yang, S., Panchenko, M.V., Toselli, P.A., Naggar, E.F., Rich, C.B., Stone, P.J., Nugent, M.A. and Panchenko, M.P. (2006): Neutrophil elastase-initiated EGFR/MEK/ERK signaling counteracts stabilizing effect of autocrine TGF-β on tropoelastin mRNA in lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol., 291, L232-L243.
4. Du, J., Wang, L., Liu, X., Zhou, H., Fan, Q., Luo, J., Yao, L., Wang, J., Feng, J. and Ma, J. (2010). Janus kinase 2/signal transducers and activators of transcription signal inhibition regulates protective effects of probucol on mesangial cells treated with high glucose. Biol. Pharm. Bul., 33, 768-772.
5. Felton, V.M., Borok, Z. and Willis, B.C. (2009): N-Acetylcysteine inhibits alveolar epithelial-mesenchymal transition. Am. J. Physiol. Lung Cell. Mol. Physiol., 297, L805-L812.
6. Franks, A.M. and Gardner, S.F. (2006): AGI-1067: a novel vascular protectant for prevention of restenosis. Ann. Pharmacother., 40, 66-73.
7. Gao, F., Kinnula, V.L., Millarniemi, M. and Oury, T.D. (2008): Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid. Redox. Signal., 10, 343-354.
8. Gauldie, J., Kolb, M., Ask, K., Martin, G., Bonniaud, P. and Warbuton, D. (2006): Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc. Am. Thorac. Soc., 3, 696-702.
9. Ghavami, S., Mutawe, M.M., Hauff, K., Stelmack, G.L., Schaafsma, D., Sharma, P., McNeill, K.D., Hynes, T.S., Kung, S.K., Unruh, H., Klonisch, T., Hatch, G.M., Los, M. and Halayko, A.J. (2010): Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochim. Biophys Acta., 1803, 452-467.
10. Hu, B., Wu, Z. and Phan, S.H. (2003): Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol., 29, 397-404.
11. Ichikawa, T., Sugiura, H., Koarai, A., Yanagisawa, S., Kanda, M., Hayata, A., Furukawa, K., Akamatsu, K., Hirano, T., Nakanishi, M., Matsunaga, K., Minakata, Y. and Ichinose, M. (2008): Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am. J. Physiol. Lung Cell. Mol. Physiol., 295, L800-L808.
12. Igarashi, R., Hoshino, J., Ochiai, A., Morizawa, Y. and Mizushima, Y. (1994): Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity. J. Pharmacol. Exp. Ther., 271, 1672-1677.
13. Kawashima, T., Wakabayashi, T., Kuroda, T., Nishide, T., Matsuzawa, Y. and Shirai, K. (2010): Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia. Respirology, 15, 1259-1265.
14. Keane, M.P., Strieter, R.M. and Belperio, J.A. (2005): Mechanisms and mediators of pulmonary fibrosis. Crit. Rev. Immunol., 25, 429-463.
15. King, T.E. Jr, Schwarz, M.I., Brown, K., Tooze, J.A., Colby, T.V., Waldron, J.A. Jr., Flint, A., Thurlbeck, W. and Cherniack, R.M. (2001): Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med., 164, 1025-1032.
16. Kinnula, V.L. and Crapo, J.D. (2003): Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med., 167, 1600-1619.
17. Kinnula, V.L., Fattman, C.L., Tan, R.J. and Oury, T.D. (2005): Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am. J. Respir. Crit. Care Med., 172, 417-422.
18. 2α-dependent and-independent release of arachidonic acid. J. Cell. Physiol., 219, 606-616.
19. Liao, J.K. and Laufs, U. (2005): Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol., 45, 89-118.
20. Liu, R.M. and Gaston Pravia, K.A. (2010): Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic. Biol. Med., 48, 1-15.
21. Moldovan, L. and Moldovan, N.I. (2004): Oxygen free radicals and redox biology of organelles. Histochem. Cell Biol., 122, 395-412.
22. Myhre, O., Andersen, J.M., Aarnes, H. and Fonnum, F. (2003) Evaluation of the probes 2',7'-dichlorofluoresscin diacetate, luminal, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol., 65, 1575-1582.
23. Ohbayashi, M., Suzuki, M., Yashiro, Y., Fukuwaka, S., Ysuda, M., Kohyama, N., Kobayashi Y. and Yamamoto, T. (2010): Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J. Toxicol. Sci., 35, 653-661.
24. Ono, A., Utsugi, M., Masubuchi, K., Ishizuka, T., Kawara, T., Shimizu, Y., Hisada, T., Hamuro, J., Mori, M. and Dobashi, K. (2009): Glutathione redox regulates TGF-β-induced fibrogenic effects through Smad3 activation. FEBS Lett., 583, 357-362.
25. Orido, T., Fujino, H., Kawashima, T. and Murayama, T. (2010): Decrease in uptake of arachidonic acid by indomethacin in LS174T human colon cancer cells: a novel cyclooxygenase-2-inhibition-independent effect. Arch. Biochem. Biophys., 494, 78-85.
26. Ostrau, C., Hulsenbeck, J., Herzog, M., Schad, A., Torzewski, M., Lackner, K.J. and Fritz, G. (2009): Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiother. Oncol., 92, 492-499.
27. Qi, S., den Hartog, G.J.M. and Bast, A. (2009): Superoxide radicals increase transforming growth factor-β1 and collagen release from human lung fibroblasts via cellular influx through chloride channels. Toxicol. Appl. Pharmacol., 237, 111-118.
28. Sadowska, A.M., Verbraecken, J., Darquennes, K. and De Backer, W.A. (2006): Role of N-acetylcysteine in the management of COPD. Int. J. Chron. Obstruct Pulmon. Dis., 1, 425-434.
29. 1-induced profibrotic responses in fibroblasts. Pulm. Pharmacol. Ther., 22, 487-491.
30. Tamagawa, K., Taooka, Y., Maeda, A., Hiyama, K., Ishioka, S. and Yamakido, M. (2000): Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med., 161, 1279-1284.
31. Tanaka, K., Ishihara, T., Azuma, A., Kudoh, S., Ebina, M., Nukiwa, T., Sugiyama, Y., Tasaka, Y., Namba, T., Ishihara, T., Sato, K., Mizushima, Y. and Mizushima, T. (2010): Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol., 298, L348-L360.
32. Tanous, D., Hime, N. and Stocker, R. (2008): Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds. Redox. Rep., 13, 48-59.
33. Tsukamoto, M., Tampo, Y., Sawada, M. and Yonaha, M. (2000): Paraquat-induced membrane dysfunction in pulmonary microvascular endothelial cells. Pharmacol. Toxicol., 86, 102-109.
34. Watts, K.L., Cottrell, E., Hoban, P.R. and Spiteri, M.A. (2006): RhoA signaling modulates cyclin D1 expression in human lung fibroblasts: implications for idiopathic pulmonary fibrosis. Respir. Res., 7, 88.
35. Yamashita, S. and Matsuzawa, Y. (2009): Where are we with probucol: a new life for an old drug? Atherosclerosis, 207, 16-23.